Oral lesions in dermatitis herpetiformis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D001768:Blister / Q000473:pathology; D003622:Dapsone / Q000627:therapeutic use; D003824:Denture, Complete / Q000009:adverse effects; D003874:Dermatitis Herpetiformis / Q000150:complications* / Q000473:pathology; D004890:Erythema; D004912:Erythrocytes; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D009504:Neutrophils; D009912:Oral Manifestations; D011693:Purpura; D011725:Pyridines / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D014059:Tongue / Q000473:pathology; D014947:Wounds and Injuries / Q000150:complications
D007070:Immunoglobulin A; D011725:Pyridines; D013424:Sulfanilamides; D003622:Dapsone